Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

The Utilization of Counseling Skills by the Laboratory Genetic Counselor
Goodenberger, McKinsey L. , Thomas, Brittany C. , Wain, Karen E. , Goodenberger, McKinsey

Journal of Genetic Counseling | August 19, 2014 | Volume: 24 | Issue: 1 | Pages: 6-17

10.1007/s10897-014-9749-9 | PMID 25138081 Get It

AbstractThe number of available genetic testing options and the nuances associated with these options continue to expand. In addition, the scope of genetic testing has broadened to areas and specialties beyond Medical Genetics. In response to these changes, diagnostic laboratories have employed genetic counselors to help navigate the increasing complexity of genetic testing, given their expertise and training in human genetics. However a largely unrecognized aspect of this role involves the use of counseling skills. Counseling skills are used by laboratory genetic counselors in a variety of situations to convey information and facilitate understanding among clinicians and medical staff. This helps to reduce test ordering errors, promote optimal test utilization, and ensure best patient care practices. The specific counseling skills used by laboratory counselors will be explored using three fictional case vignettes, followed by a discussion of the applicability of these skills in other contexts. Exploration of the unique ways in which laboratory genetic counselors apply their counseling skills can be useful for professional development and instructive for graduate training programs.
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
Jagsi, Reshma , Chadha, Manjeet , Moni, Janaki, Laurie, Fran, Buchholz, Thomas A. , Giuliano, Armando E. , Haffty, Bruce G. , Ballman, Karla, Giuliano, Armando, Ballman, Karla V. , Jagsi, Reshma

Journal of Clinical Oncology | August 19, 2014 | Volume: 32 | Issue: 32 | Pages: 3600-3606

10.1200/jco.2014.56.5838 | PMID 25135994 Get It

Purpose ACOSOG Z0011 established that axillary lymph node dissection (ALND) is unnecessary in patients with breast cancer with one to two positive sentinel lymph nodes (SLNs) who undergo lumpectomy, radiotherapy (RT), and systemic therapy. We sought to ascertain RT coverage of the regional nodes in that trial. Methods We evaluated case report forms completed 18 months after enrollment. From 2012 to 2013, we collected all available detailed RT records for central review. Results Among 605 patients with completed case report forms, 89% received whole-breast RT. Of these, 89 (15%) were recorded as also receiving treatment to the supraclavicular region. Detailed RT records were obtained for 228 patients, of whom 185 (81.1%) received tangent-only treatment. Among 142 with sufficient records to evaluate tangent height, high tangents (cranial tangent border ≤ 2 cm from humeral head) were used in 50% of patients (33 of 66) randomly assigned to ALND and 52.6% (40 of 76) randomly assigned to SLND. Of the 228 patients with records reviewed, 43 (18.9%) received directed regional nodal RT using ≥ three fields: 22 in the ALND arm and 21 in the SLND arm. Those receiving directed nodal RT had greater nodal involvement (P < .001) than those who did not. Overall, there was no significant difference between treatment arms in the use of protocol-prohibited nodal fields. Conclusion Most patients treated in Z0011 received tangential RT alone, and some received no RT at all. Some patients received directed nodal irradiation via a third field. Further research is necessary to determine the optimal RT approach in patients with low-volume axillary disease treated with SLND alone.
Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
Nowakowski, Grzegorz S. , LaPlant, Betsy, Macon, William R. , Reeder, Craig B. , Foran, James M. , Nelson, Garth D. , Thompson, Carrie A. , Rivera, Candido E., Inwards, David J. , Micallef, Ivana N. , Johnston, Patrick B., Porrata, Luis F. , Ansell, Stephen M., Gascoyne, Randy D. , Johnston, Patrick B. , Habermann, Thomas M. , Witzig, Thomas E.

Journal of Clinical Oncology | August 19, 2014 | Volume: 33 | Issue: 3 | Pages: 251-257

10.1200/jco.2014.55.5714 | PMID 25135992 Get It

Purpose Lenalidomide has significant single-agent activity in relapsed diffuse large B-cell lymphoma (DLBCL). We demonstrated that lenalidomide can be safely combined with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone); this new combination is known as R2CHOP. The goal of this phase II study was to evaluate the efficacy of this combination in newly diagnosed DLBCL. Patients and Methods Eligible patients were adults with newly diagnosed untreated stages II to IV CD20 + DLBCL. Patients received lenalidomide 25 mg orally per day on days 1 through 10 with standard-dose R-CHOP every 21 days for six cycles. All patients received pegfilgrastim on day 2 of each cycle and aspirin prophylaxis throughout. DLBCL molecular subtype was determined by tumor immunohistochemistry and classified as germinal center B-cell (GCB) versus non-GCB in the R2CHOP patients and 87 control patients with DLBCL from the Lymphoma Database who were treated with conventional R-CHOP. Results In all, 64 patients with DLBCL were enrolled, and 60 were evaluable for response. The overall response rate was 98% (59 of 60) with 80% (48 of 60) achieving complete response. Event-free survival and overall survival (OS) rates at 24 months were 59% (95% CI, 48% to 74%) and 78% (95% CI, 68% to 90%), respectively. In R-CHOP patients, 24-month progression-free survival (PFS) and OS were 28% versus 64% (P < .001) and 46% versus 78% (P < .001) in non-GCB DLBCL versus GCB DLBCL, respectively. In contrast, there was no difference in 24-month PFS or OS for R2CHOP patients on the basis of non-GCB and GCB subtype (60% v 59% [P = .83] and 83% v 75% [P = .61] at 2 years, respectively). Conclusion R2CHOP shows promising efficacy in DLBCL. The addition of lenalidomide appears to mitigate a negative impact of non-GCB phenotype on patient outcome.
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry
Barnidge, David R. , Dasari, Surendra , Ramı́rez-Alvarado, Marina , Fontan, Adrian, Tschumper, Renee C. , Jelinek, Diane F., Snyder, Melissa R., Dispenzieri, Angela , Katzmann, Jerry A., Murray, David , Willrich, Maria Alice V. , Snyder, Melissa R., Dispenzieri, Angela , Ramirez-Alvarado, Marina

Journal of Proteome Research | August 19, 2014 | Volume: 13 | Issue: 11 | Pages: 5198-5205

10.1021/pr5005967 | PMID 25134970 Get It

Review: In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment
Smith, Steven C. , McCoy, Rozalina G.

Annals of Internal Medicine | August 18, 2014 | Volume: 161 | Issue: 4 | Pages: JC2

10.7326/0003-4819-161-4-201408190-02002 | PMID 25133381 Get It

Bariatric surgery improved HbA1c more than intensive medical therapy in obese patients with uncontrolled type 2 DM
Leon, B. Gisella Carranza, Montori, Víctor M. , Montori, Victor M

Annals of Internal Medicine | August 18, 2014 | Volume: 161 | Issue: 4 | Pages: JC4

10.7326/0003-4819-161-4-201408190-02004 | PMID 25133383 Get It

The Art of Story
Cognetta-Rieke, Cheristi

Creative Nursing | August 18, 2014 | Volume: 20 | Issue: 3 | Pages: 153-158

10.1891/1078-4535.20.3.153 | PMID 25252376 Get It

Story is an intimate human resource to describe our being within the world. This article demonstrates the use of this human resource within a patient- and family-centered care initiative developed with and for the pediatric patient population. It describes the purpose, objectives, and design of the MyStory initiative as well as its impact on patient satisfaction scores. Finally, this article challenges current methods of data collection and assessment to include patient stories in order to involve children in care planning and decision making to ensure whole-person care.
Diagnostic and therapeutic spinal interventions
Maus, Timothy P. , Bartleson, J. D.

Neurology Clinical Practice | August 18, 2014 | Volume: 4 | Issue: 4 | Pages: 353-357

10.1212/cpj.0000000000000045 | PMID 29473562 Get It

Diagnostic and therapeutic spinal interventions
Bartleson, J. D., Maus, Timothy P.

Neurology Clinical Practice | August 18, 2014 | Volume: 4 | Issue: 4 | Pages: 342-346

10.1212/cpj.0000000000000044 | PMID 29473559 Get It

Diagnostic and therapeutic spinal interventions
Bartleson, J. D., Maus, Timothy P.

Neurology Clinical Practice | August 18, 2014 | Volume: 4 | Issue: 4 | Pages: 347-352

10.1212/cpj.0000000000000043 | PMID 29473564 Get It